Persistent neutrophilia is a marker for an increased risk of venous thrombosis

Journal of Thrombosis and Thrombolysis

Volumn 42, Issue 4, 2016, Pages 545-551

  Kushnir, Margarita ^a   Cohen, Hillel W ^a   Billett, Henny H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Diabetes; Leukocytosis; Neutrophilia; Obesity; Venous thrombosis

Indexed keywords

ADULT; ARTICLE; CHARLSON COMORBIDITY INDEX; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; ICD-9; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL COUNT; NEUTROPHILIA; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; VEIN THROMBOSIS; BLOOD; COMPLICATION; LEUKOCYTE COUNT; NEUTROPENIA; RISK FACTOR; VENOUS THROMBOEMBOLISM;

BIOLOGICAL MARKER;

ADULT; BIOMARKERS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; NEUTROPENIA; RISK FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84978120409     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-016-1398-4     Document Type: Article

References (44)

1. Carobbio A, Finazzi G, Guerini V, Spinelli O, Delaini F, Marchioli R et al (2007) Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status. Blood 109:2310–2313
2. Landolfi R, Di Gennaro L, Barbui T, De Stefano V, Finazzi G, Marfisi R et al (2007) Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera. Blood 109:2446–2452
3. Palandri F, Polverelli N, Catani L, Ottaviani E, Baccarani M, Vianelli N (2011) Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia. Ann Hematol 90:933–938
4. Angona A, Alvarez-Larran A, Bellosillo B, Martinez-Aviles L, Garcia-Pallarols F, Longaron R et al (2015) Essential thrombocythemia: baseline characteristics and risk factors for survival and thrombosis in a series of 214 patients. Med Clin (Barc) 144:247–253
5. Passamonti F, Caramezza D, Mora B, Casalone R, Maffioli M (2014) Is it time to change thrombosis risk assessment for PV and ET? Best Pract Res Clin Haematol 27:121–127
6. Buxhofer-Ausch V, Gisslinger H, Thiele J, Gisslinger B, Kvasnicka HM, Müllauer L et al (2012) Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: an international study of 264 patients. Am J Hematol 87:669–672
7. Wang Z, Yan HH, Yang JJ, Wang BC, Chen HJ, Zhou Q et al (2015) Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients. Support Care Cancer 23:635–641
8. Zhang Y, Yang Y, Chen W, Guo L, Liang L, Zhai Z et al (2014) Prevalence and associations of VTE in patients with newly diagnosed lung cancer. Chest 146:650–658
9. Connolly GC, Khorana AA, Kuderer NM, Culakova E, Francis CW, Lyman GH (2010) Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy. Thromb Res 126:113–118
10. Blix K, Jensvoll H, Brækkan S, Hansen J (2013) White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism—The Tromsø Study. PLoS One 8:e73447
11. Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr et al (2010) Extracellular DNA traps promote thrombosis. PNAS 107:15880–15885
12. Borissoff JI, ten Cate H (2011) From neutrophil extracellular traps release to thrombosis: an overshooting host-defense mechanism? J Thromb Haemost 9:1791–1794
13. Martinod K, Wagner DD (2014) Thrombosis: tangled up in NETs. Blood 123:2768–2776
14. Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C et al (2010) Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 16:887–896
15. Levi M, van der Poll T, Buller HR (2004) Bidirectional relation between inflammation and coagulation. Circulation 109:2698–2704
16. Ruf W, Ruggeri ZM (2010) Neutrophils release brakes of coagulation. Nat Med 16:851–852
17. Ruggeri ZM (2007) The role of von Willebrand factor in thrombus formation. Thromb Res 120(Suppl 1):S5–S9
18. Jimenez-Alcazar M, Napirei M, Panda R, Kohler EC, Kremer-Hovinga JA, Mannherz HG et al (2015) Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies. J Thromb Haemost 5:732–742
19. von Bruhl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M et al (2012) Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 209:819–835
20. Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL et al (2011) Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 118:1952–1961
21. Savchenko AS, Martinod K, Seidman MA, Wong SL, Borissoff JI, Piazza G et al (2014) Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development. J Thromb Haemost 12:860–870
22. Borissoff JI, Joosen IA, Versteylen MO, Brill A, Fuchs TA, Savchenko AS et al (2013) Elevated levels of circulating DNA and chromatin are indepndently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol 33:2032–2040
23. van Montfoort ML, Stephan F, Lauw MN, Hutten BA, Van Mierlo GJ, Solati S et al (2013) Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis. Arterioscler Thromb Vasc Biol 33:147–151
24. Brill A, Fuchs TA, Savchenko AS, Thomas GM, Martinod K, De Meyer SF et al (2012) Neutrophil extracellular traps promote deep venous thrombosis in mice. J Thromb Haemost 10:136–144
25. Stakos DA, Kambas K, Konstantinidis T, Mitroulis I, Apostolidou E, Arelaki S et al (2015) Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction. Eur Heart J 36:1405–1414
26. Martinod K, Demers M, Fuchs TA, Wong SL, Brill A, Gallant M et al (2013) Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. PNAS 110:8674–8679
27. Olson NC, Cushman M, Lutsey PL, McClure LA, Judd S, Tracy RP et al (2014) Inflammation markers and incident venous thromboembolism: the reasons for geographic and racial differences in stroke (REGARDS) cohort. J Thromb Haemost 12:1993–2001
28. Wang TF, Wong CA, Milligan PE, Thoelke MS, Woeltje KF, Gage BF (2014) Risk factors for inpatient venous thromboembolism despite thromboprophylaxis. Thromb Res 133:25–29
29. Borch KH, Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J et al (2010) Anthropometric measures of obesity and risk of venous thromboembolism: the Tromso study. Arterioscler Thromb Vasc Biol 30:121–127
30. Ay C, Tengler T, Vormittag R, Simanek R, Dorda W, Vukovich T et al (2007) Venous thromboembolism—a manifestation of the metabolic syndrome. Haematologica 92:374–380
31. Jang MJ, Choi WI, Bang SM, Lee T, Kim YK, Ageno W et al (2009) Metabolic syndrome is associated with venous thromboembolism in the Korean population. Arterioscler Thromb Vasc Biol 29:311–315
32. Di Minno MN, Tufano A, Guida A, Di Capua M, De Gregorio AM, Cerbone AM et al (2011) Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. Thromb Res 127:193–197
33. Vaya A, Martinez-Triguero ML, Espana F, Todolí JA, Bonet E, Corella D (2011) The metabolic syndrome and its individual components: its association with venous thromboembolism in a Mediterranean population. Metab Syndr Relat Disord 9:197–201
34. Stein PD, Goldman J, Matta F, Yaekoub AY (2009) Diabetes mellitus and risk of venous thromboembolism. Am J Med Sci 337:259–264
35. Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW (2005) The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia 48:1017–1021
36. Steffen LM, Cushman M, Peacock JM, Heckbert SR, Jacobs DR Jr, Rosamond WD et al (2009) Metabolic syndrome and risk of venous thromboembolism: longitudinal investigation of thromboembolism etiology. J Thromb Haemost 7:746–751
37. Ageno W, Prandoni P, Romualdi E, Ghirarduzzi A, Dentali F, Pesavento R et al (2006) The metabolic syndrome and the risk of venous thrombosis: a case–control study. J Thromb Haemost 4:1914–1918
38. Eichinger S, Hron G, Bialonczyk C, Hirschl M, Minar E, Wagner O et al (2008) Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med 168:1678–1683
39. Weir AB, Lewis JB Jr, Arteta-Bulos R (2011) Chronic idiopathic neutrophilia: experience and recommendations. South Med J 104:499–504
40. Herishanu Y, Rogowski O, Polliack A, Marilus R (2006) Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol 76:516–520
41. Vaidyula VR, Rao AK, Mozzoli M, Homko C, Cheung P, Boden G (2006) Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes 55:202–208
42. Ray JG, Lonn E, Yi Q, Sheridan P, Kearon C, Yusuf S, Arnold MJ, McQueen MJ, Pogue J, Probstfield J, Fodor G, Held C, Micks M, Genest J Jr, HOPE-2 investigators (2007) Venous thromboembolism in association with features of the metabolic syndrome. QJM 100:679–684
43. Thobakgale CF, Ndung’u T (2014) Neutrophil counts in persons of African origin. Curr Opin Hematol 21:50–57
44. Mazurek JA, Hailpern SM, Goring T, Nordin C (2010) Prevalence of hemoglobin A1c greater than 6.5 and 7.0 % among hospitalized patients without known diagnosis of diabetes at an urban inner city hospital. J Clin Endocrinol Metab 95:1344–1348